.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Federal Trade Commission
Deloitte
Colorcon
Mallinckrodt
Healthtrust
AstraZeneca
Cerilliant
QuintilesIMS

Generated: January 22, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Canada Patent: 2307547

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-001Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION AND ANGINA PECTORIS
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-002Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION AND ANGINA PECTORIS
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-003Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION AND ANGINA PECTORIS
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-004Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION AND ANGINA PECTORIS
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-005Feb 6, 2003ABRXYesNo➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION AND ANGINA PECTORIS
Valeant IntlCARDIZEM LAdiltiazem hydrochlorideTABLET, EXTENDED RELEASE;ORAL021392-006Feb 6, 2003ABRXYesYes➤ Subscribe➤ SubscribeYTREATMENT OF HYPERTENSION AND ANGINA PECTORIS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist